Dataset Information
Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma.
Ontology highlight
ABSTRACT: Background and purpose
Proton therapy is increasingly used to treat primary brain tumors. There is concern for higher rates of pseudoprogression (PsP) after protons compared to photons. The purposes of this study are to compare the rate of PsP after proton vs. photon therapy for grade II and III gliomas and to identify factors associated with the development of PsP.Materials and methods
Ninety-nine patients age >18?years with grade II or III glioma treated with photons or protons were retrospectively reviewed. Demographic data, IDH and 1p19q status, and treatment factors were analyzed for association with PsP, progression free survival (PFS), and overall survival (OS).Results
Sixty-five patients were treated with photons and 34 with protons. Among those with oligodendroglioma, PsP developed in 6/42 photon-treated patients (14.3%) and 4/25 proton-treated patients (16%, p?=?1.00). Among those with astrocytoma, PsP developed in 3/23 photon-treated patients (13%) and 1/9 proton-treated patients (11.1%, p?=?1.00). There was no difference in PsP rate based on radiation type, radiation dose, tumor grade, 1p19q codeletion, or IDH status. PsP occurred earlier in oligodendroglioma patients treated with protons compared to photons, 48?days vs. 131?days, p?ConclusionsPatients with oligodendroglioma but not astrocytoma develop PsP earlier after protons compared to photons. PsP was associated with better PFS.
SUBMITTER: Bronk JK
PROVIDER: S-EPMC5862685 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
Publications
Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma.
Clinical and translational radiation oncology 20180112
<h4>Background and purpose</h4>Proton therapy is increasingly used to treat primary brain tumors. There is concern for higher rates of pseudoprogression (PsP) after protons compared to photons. The purposes of this study are to compare the rate of PsP after proton vs. photon therapy for grade II and III gliomas and to identify factors associated with the development of PsP.<h4>Materials and methods</h4>Ninety-nine patients age >18 years with grade II or III glioma treated with photons or protons ...[more]
